Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Vivos Therapeutics, Inc. (VVOS)

0.48   -0.01 (-2.06%) 12-02 15:38
Open: 0.4811 Pre. Close: 0.4901
High: 0.4901 Low: 0.45
Volume: 50,604 Market Cap: 11(M)

Technical analysis

as of: 2022-12-02 4:27:10 PM
Stoxline posted a SELL today, same as yesterday. Downward movement continues.
Target: Six months: 0.77     One year: 0.93
Support: Support1: 0.44    Support2: 0.37
Resistance: Resistance1: 0.66    Resistance2: 0.8
Pivot: 0.58
Moving Average: MA(5): 0.51     MA(20): 0.6
MA(100): 0.96     MA(250): 1.66
MACD: MACD(12,26): -0.1     Signal(9): -0.1
Stochastic oscillator: %K(14,3): 3.4     %D(3): 3.9
RSI: RSI(14): 30.3
52-week: High: 3.69  Low: 0.44
Average Vol(K): 3-Month: 36 (K)  10-Days: 36 (K)

Price, moving averages and Bollinger Bands

Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.
[ VVOS ] has closed above bottom band by 8.1%. Bollinger Bands are 8.3% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 0.49 - 0.5 0.5 - 0.5
Low: 0.44 - 0.45 0.45 - 0.45
Close: 0.47 - 0.48 0.48 - 0.49

Company Description

Vivos Therapeutics, Inc., a medical technology company, develops and commercializes treatment alternatives for patients with dentofacial abnormalities, obstructive sleep apnea (OSA), and snoring in adults. It offers the Vivos System, a non-invasive, non-surgical, non-pharmaceutical, multi-disciplinary treatment modality for the treatment of dentofacial abnormalities, OSA, and snoring. Vivos Therapeutics also offers VivoScore Program, a screening and home sleep test in adults and children. The company markets and sells its Vivos System to licensed professionals, primarily general dentists in the United States and Canada. Vivos Therapeutics, Inc. was founded in 2016 and is based in Highlands Ranch, Colorado.

Headline News

Tue, 22 Nov 2022
Vivos Therapeutics (VVOS) Provides Update on Revenue Recognition Review -

Tue, 23 Aug 2022
Vivos Announces 4th Annual Breathing Wellness Conference in CancĂșn, Mexico, With Full Slate of World-Renowned Speakers - GlobeNewswire

Mon, 15 Aug 2022
Vivos Therapeutics to Reschedule Second Quarter 2022 Financial Results Conference Call - GlobeNewswire

Thu, 14 Jul 2022
Vivos Therapeutics Announces Multiple Regulatory Clearances in Australia for Its Entire Line of Oral Appliances - Business Wire

Wed, 29 Jun 2022
Vivos Therapeutics Announces Exclusive Distribution Agreement with GM Instruments, Ltd. for the US and Canada - GlobeNewswire

Thu, 31 Mar 2022
Vivos Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results and Operational Update - GlobeNewswire

Financial Analysis

Price to Book Value: Outperform
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Price to Earnings: Underperform
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Discounted cash flow: Outperform
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Return on Assets: Underperform
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Return on Equity: Underperform
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Debt to Equity: Neutral
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Medical Devices
Shares Out. 23 (M)
Shares Float 18 (M)
% Held by Insiders 21.6 (%)
% Held by Institutions 8.9 (%)
Shares Short 218 (K)
Shares Short P.Month 169 (K)

Stock Financials

EPS -1.02
EPS Est Next Qtl 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 0.91
Profit Margin (%) -132.6
Operating Margin (%) -135.5
Return on Assets (ttm) -55.6
Return on Equity (ttm) -127.4
Qtrly Rev. Growth 0.3
Gross Profit (p.s.) 0.54
Sales Per Share 0.73
EBITDA (p.s.) -0.97
Qtrly Earnings Growth 0
Operating Cash Flow -18 (M)
Levered Free Cash Flow -14 (M)

Stock Valuations

PE Ratio -0.48
PEG Ratio 0
Price to Book value 0.52
Price to Sales 0.65
Price to Cash Flow -0.62

Stock Dividends

Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
Your Ad Here
StockChart iOS
StoxlineLite iOS
StoxlineLite iOS
OptionCalc iOS
StockChart Android
StoxlineLite Android
StoxlinePro Android
OptionCalc Android
(c) 2006-2022 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.